These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The prevalence and diagnostic value of perinuclear antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibodies in patients with inflammatory bowel disease in mainland China. Zhou F; Xia B; Wang F; Shrestha UK; Chen M; Wang H; Shi X; Chen Z; Li J Clin Chim Acta; 2010 Oct; 411(19-20):1461-5. PubMed ID: 20570669 [TBL] [Abstract][Full Text] [Related]
11. Serological markers of inflammatory bowel disease in children from the Western region of Saudi Arabia. Saadah OI; Al-Mughales JA Arab J Gastroenterol; 2013 Jun; 14(2):78-82. PubMed ID: 23820506 [TBL] [Abstract][Full Text] [Related]
12. Autoantibodies pANCA, GAB and PAB in inflammatory bowel disease: prevalence, characteristics and diagnostic value. Homsak E; Micetić-Turk D; Bozic B Wien Klin Wochenschr; 2010 May; 122 Suppl 2():19-25. PubMed ID: 20517666 [TBL] [Abstract][Full Text] [Related]
13. Anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease. Koutroubakis IE; Petinaki E; Mouzas IA; Vlachonikolis IG; Anagnostopoulou E; Castanas E; Maniatis AN; Kouroumalis EA Am J Gastroenterol; 2001 Feb; 96(2):449-54. PubMed ID: 11232689 [TBL] [Abstract][Full Text] [Related]
14. [Diagnostic role of anti-saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease]. Gao X; Hu PJ; He Y; Liao SY; Peng S; Chen MH Zhonghua Nei Ke Za Zhi; 2005 Jun; 44(6):428-30. PubMed ID: 16008854 [TBL] [Abstract][Full Text] [Related]
15. Serological markers in diagnosis of pediatric inflammatory bowel disease and as predictors for early tumor necrosis factor blocker therapy. Olbjørn C; Cvancarova Småstuen M; Thiis-Evensen E; Nakstad B; Vatn MH; Perminow G Scand J Gastroenterol; 2017 Apr; 52(4):414-419. PubMed ID: 27887202 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic role of anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic antibodies in patients with inflammatory bowel disease. Kim BG; Kim YS; Kim JS; Jung HC; Song IS Dis Colon Rectum; 2002 Aug; 45(8):1062-9. PubMed ID: 12195191 [TBL] [Abstract][Full Text] [Related]
17. Relationship between ANCA and clinical activity in inflammatory bowel disease: variation in prevalence of ANCA and evidence of heterogeneity. Abad E; Tural C; Mirapeix E; Cuxart A J Autoimmun; 1997 Apr; 10(2):175-80. PubMed ID: 9185879 [TBL] [Abstract][Full Text] [Related]
18. Prevalence and significance of perinuclear anti-neutrophil antibodies (pANCA) in Romanian patients with Crohn's disease and ulcerative colitis. Preda CM; Vermeire S; Rutgeerts P; Joosens S; Diculescu M; Marica C; Ciocarlan M; Mirea V; Oproiu A Rom J Gastroenterol; 2005 Dec; 14(4):357-60. PubMed ID: 16400351 [TBL] [Abstract][Full Text] [Related]
19. PR3-ANCA: a promising biomarker for ulcerative colitis with extensive disease. Mahler M; Bogdanos DP; Pavlidis P; Fritzler MJ; Csernok E; Damoiseaux J; Bentow C; Shums Z; Forbes A; Norman GL Clin Chim Acta; 2013 Sep; 424():267-73. PubMed ID: 23806819 [TBL] [Abstract][Full Text] [Related]
20. Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis. Hov JR; Boberg KM; Taraldsrud E; Vesterhus M; Boyadzhieva M; Solberg IC; Schrumpf E; Vatn MH; Lie BA; Molberg Ø; Karlsen TH Liver Int; 2017 Mar; 37(3):458-465. PubMed ID: 27558072 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]